Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prenatal immune activation in rats and adult exposure to inescapable shocks reveal sex-dependent effects on fear conditioning that might be relevant for schizophrenia

  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Fuentes, Silvia|||0000-0002-8352-1068
  • Visa Bombardo, Joan|||0000-0002-9675-9999
  • Belda, Xavier|||0000-0003-0374-9546
  • Serrano, Sara
  • Labad, Javier|||0000-0003-2214-1886
Prenatal infection is considered a relevant factor for neurodevelopmental alterations and psychiatric diseases. Administration of bacterial and viral components during pregnancy in rodents results in maternal immune activation (MIA), leading to schizophrenia-like neurochemical and behavioral changes. Despite some evidence for abnormal fear conditioning in schizophrenia, only a few animal studies have focused on this issue. Therefore, we addressed the impact of the administration of the viral mimetic polyI:C to pregnant Long-Evans rats on the adult offspring response to inescapable shocks (IS) and contextual fear conditioning. In males, polyI:C induced a greater endocrine (plasma ACTH) response to IS and both polyI:C and IS enhanced fear conditioning and generalization to a completely different novel environment (hole-board), with no additive effects, probably due to a ceiling effect. In contrast, a modest impact of polyI:C and a lower impact of IS on contextual fear conditioning and generalization was observed in females. Thus, the present results demonstrate that polyI:C dramatically affected fear response to IS in adult males and support the hypothesis that males are more sensitive than females to this treatment. This model might allow to explore neurobiological mechanisms underlying abnormal responsiveness to fear conditioning and stressors in schizophrenia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Clozapine use and COVID-19 risk, A systematic review, meta-analysis, and retrospective cohort evidence

  • Sagués, Teresa
  • Ferrer, Alex|||0000-0002-3040-1177
  • Delgado, Juan Francisco|||0000-0002-8751-8309
  • Julia Agullo, German|||0009-0003-0995-4011
  • Rodríguez-González, Raquel|||0000-0002-2242-6454
  • Ruiz, Àngels
  • Estrada, Francesc
  • Soria, Virgina
  • Palao, Diego|||0000-0002-3323-6568
  • Labad, Javier|||0000-0003-2214-1886
  • Montalvo Aguirrezabala, Itziar|||0000-0002-7320-5109
Background: Clozapine's immune-modulating effects, including neutropenia and suppression of adaptive immunity, have raised concerns about its potential impact on SARS-CoV-2 infection risk and COVID-19 severity in individuals with treatment-resistant schizophrenia. Findings in the literature remain inconsistent. Methods: First, we conducted a longitudinal retrospective study in which we analysed 995 outpatients with severe mental disorders receiving antipsychotic treatment to assess the association between clozapine use and SARS-CoV-2 infection and disease severity. Secondly, we performed a systematic review of the literature and searched for studies published up to July 2025 examining the link between clozapine exposure and SARS-CoV-2 infection. Eight cohort studies plus our dataset were meta-analysed using a random-effects model. Results: In our cohort, clozapine users demonstrated a higher rate of SARS-CoV-2 infection (18% vs. 10%, p < 0.001) and increased COVID-19 severity compared to non-users. The meta-analysis comprised 155,945 participants, with individual study ORs ranging from 0.40 to 2.80. The pooled random-effects OR was 1.53 (95% CI: 1.02-2.30, p = 0.044), indicating a significant association between clozapine exposure and increased infection risk. However, high heterogeneity (I² = 91.2%) suggests variation in effects across studies. Conclusions: Clozapine treatment is associated with an increased risk and severity of SARS-CoV-2 infection. Although meta-analytic results support this association, substantial heterogeneity in pooled estimates highlights the need for further research to clarify underlying clinical and methodological factors influencing risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma profiles of neurology-related proteins in at-risk mental state and first-episode psychosis, Associations with psychotic symptoms and cognitive performance

  • Llaurador-Coll, Martí
  • Montalvo Aguirrezabala, Itziar|||0000-0002-7320-5109
  • Estrada, Francesc
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Labad, Javier|||0000-0003-2214-1886
  • Benedet, Andrea L.
  • Vilella, Elisabet|||0000-0002-1887-5919
Early diagnosis of psychosis is crucial, and biomarker detection may provide insights into the pathophysiology of psychosis and the potential for the development of early diagnostic tools. In particular, blood-based proteomic profiling has yielded promising results for psychiatric disorders because of the use of novel high-throughput techniques and the feasibility of performing blood extractions in routine clinical practice. Here, we studied 182 participants (33.3 % females, = 24.66 ± 5.05), comprising 50 healthy controls (HCs), 37 patients with an at-risk mental state (ARMS) and 95 patients with a first episode of psychosis (FEP). We used a panel of 92 neurology-related proteins in a multiplex immunoassay to identify the plasma protein profiles of each group, their coexpression patterns and biological relevance, and their associations with psychotic symptoms and cognitive performance. CPA2 was overexpressed in both ARMS participants (β = 0.876, adj. p = 0.009) and FEP participants (β = 0.568, adj. p = 0.011) compared with HCs. In FEP participants, in addition to CPA2, 31 other proteins were overexpressed, with GFRA1 being the most differentially expressed protein (β = 1.159, adj. p.